.

Analysis of 8-plex multiplex IF staining in CRC & NSCLC tissue – Ultivue staining

OracleBio Case Study

Note: Permission has been granted for the use of this material

Study Background

Analysis of 8-plex multiplex IF staining in CRC & NSCLC tissue – Ultivue staining

This study’s aim was to utilise high-plex staining and quantitative analysis to more clearly define the underling biology across CRC and NSCLC cancer indications.

Sample Details

CRC and NSCLC

Staining

Ultivue panel included CD3, CD4, CD8, FOXP3, CD68/CD163, PD-1, PD L1, and a pan CK/SOX10 cocktail as a tumour indicator.

Analysis

All image analysis performed using Visiopharm software.

View the Case Study

Click the thumbnail below to view the case study PDF:

Multiplex Digital Phenotyping of the Tumour Microenvironment AACR 2021

Benefits of Working with OracleBio for your Clinical Studies:

 

  • Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
  • Work alongside Clinical Project managers – experienced with ensuring data parity between time-separated batches of clinical samples